Surgery for Urinary Incontinence – When the Sling’s the Thing
Surgery may be indicated for women with stress (not urge) urinary incontinence who have failed conservative management (see ‘Related ObG Topics’ below) or who decline conservative management
Synthetic mid-urethral mesh slings are the most common primary surgical treatment for women with stress urinary incontinence (SUI) and are recognized as standard of care by the AUGS and others
Slings may be retropubic or transobturator
Subjective cure rates range from 62% to 97% and are similar for both approaches
Surgery for stress urinary incontinence (SUI) is generally well tolerated with excellent cure rates for either retropubic or transobturator mesh slings. Voiding dysfunction, bladder perforation, vascular and/or visceral injury as well as operative blood loss are more common with retropubic slings. Groin pain, sometimes debilitating, is more common with transobturator slings. Autologous fascial bladder slings are appropriate in women with severe SUI and a nonmobile, fixed urethra (generally secondary to scarring from previous surgery), urethral diverticula or fistula, or complications from previously placed vaginal mesh.
Women with both pelvic organ prolapse and SUI should have concomitant surgical treatment of both
Women with pelvic organ prolapse and no SUI may develop SUI after surgical correction of prolapse, and should be evaluated preoperatively by performing a cough stress test, with the prolapse reduced
Women with pelvic organ prolapse, and without SUI who are undergoing either abdominal or vaginal prolapse repair should be counseled that postoperative SUI may occur unless an additional procedure is performed to prevent it
The risk of adverse effects is increased with the additional procedure
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan